107 related articles for article (PubMed ID: 30139269)
1. Evaluation of curcumin, a natural product in turmeric, on Burkitt lymphoma and acute myeloid leukemia cancer stem cell markers.
Li Y; Domina A; Lim G; Chang T; Zhang T
Future Oncol; 2018 Oct; 14(23):2353-2360. PubMed ID: 30139269
[TBL] [Abstract][Full Text] [Related]
2. Curcumin attenuates resistance to irinotecan via induction of apoptosis of cancer stem cells in chemoresistant colon cancer cells.
Su P; Yang Y; Wang G; Chen X; Ju Y
Int J Oncol; 2018 Sep; 53(3):1343-1353. PubMed ID: 29956726
[TBL] [Abstract][Full Text] [Related]
3. Curcumin and epigallocatechin gallate inhibit the cancer stem cell phenotype via down-regulation of STAT3-NFκB signaling.
Chung SS; Vadgama JV
Anticancer Res; 2015 Jan; 35(1):39-46. PubMed ID: 25550533
[TBL] [Abstract][Full Text] [Related]
4. Curcumin inhibits bladder cancer stem cells by suppressing Sonic Hedgehog pathway.
Wang D; Kong X; Li Y; Qian W; Ma J; Wang D; Yu D; Zhong C
Biochem Biophys Res Commun; 2017 Nov; 493(1):521-527. PubMed ID: 28870814
[TBL] [Abstract][Full Text] [Related]
5. Sanguinarine inhibits pancreatic cancer stem cell characteristics by inducing oxidative stress and suppressing sonic hedgehog-Gli-Nanog pathway.
Ma Y; Yu W; Shrivastava A; Alemi F; Lankachandra K; Srivastava RK; Shankar S
Carcinogenesis; 2017 Oct; 38(10):1047-1056. PubMed ID: 28968696
[TBL] [Abstract][Full Text] [Related]
6. Curcumin decreases malignant characteristics of glioblastoma stem cells via induction of reactive oxygen species.
Gersey ZC; Rodriguez GA; Barbarite E; Sanchez A; Walters WM; Ohaeto KC; Komotar RJ; Graham RM
BMC Cancer; 2017 Feb; 17(1):99. PubMed ID: 28160777
[TBL] [Abstract][Full Text] [Related]
7. Sonic hedgehog and Wnt/β-catenin pathways mediate curcumin inhibition of breast cancer stem cells.
Li X; Wang X; Xie C; Zhu J; Meng Y; Chen Y; Li Y; Jiang Y; Yang X; Wang S; Chen J; Zhang Q; Geng S; Wu J; Zhong C; Zhao Y
Anticancer Drugs; 2018 Mar; 29(3):208-215. PubMed ID: 29356693
[TBL] [Abstract][Full Text] [Related]
8. Curcumin Suppresses Lung Cancer Stem Cells via Inhibiting Wnt/β-catenin and Sonic Hedgehog Pathways.
Zhu JY; Yang X; Chen Y; Jiang Y; Wang SJ; Li Y; Wang XQ; Meng Y; Zhu MM; Ma X; Huang C; Wu R; Xie CF; Li XT; Geng SS; Wu JS; Zhong CY; Han HY
Phytother Res; 2017 Apr; 31(4):680-688. PubMed ID: 28198062
[TBL] [Abstract][Full Text] [Related]
9. Smad inhibitor induces CSC differentiation for effective chemosensitization in cyclin D1- and TGF-β/Smad-regulated liver cancer stem cell-like cells.
Xia W; Lo CM; Poon RYC; Cheung TT; Chan ACY; Chen L; Yang S; Tsao GSW; Wang XQ
Oncotarget; 2017 Jun; 8(24):38811-38824. PubMed ID: 28415588
[TBL] [Abstract][Full Text] [Related]
10. Targeting cancer stem cells by curcumin and clinical applications.
Li Y; Zhang T
Cancer Lett; 2014 May; 346(2):197-205. PubMed ID: 24463298
[TBL] [Abstract][Full Text] [Related]
11. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
[TBL] [Abstract][Full Text] [Related]
12. A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors.
Lim KJ; Bisht S; Bar EE; Maitra A; Eberhart CG
Cancer Biol Ther; 2011 Mar; 11(5):464-73. PubMed ID: 21193839
[TBL] [Abstract][Full Text] [Related]
13. NANOG Expression as a Responsive Biomarker during Treatment with Hedgehog Signal Inhibitor in Acute Myeloid Leukemia.
Kakiuchi S; Minami Y; Miyata Y; Mizutani Y; Goto H; Kawamoto S; Yakushijin K; Kurata K; Matsuoka H; Minami H
Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28245563
[TBL] [Abstract][Full Text] [Related]
14. Curcumin and cancer stem cells: curcumin has asymmetrical effects on cancer and normal stem cells.
Sordillo PP; Helson L
Anticancer Res; 2015 Feb; 35(2):599-614. PubMed ID: 25667437
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic target discovery and drug development in cancer stem cells for leukemia and lymphoma: from bench to the clinic.
Laranjeira AB; Yang SX
Expert Opin Drug Discov; 2016 Nov; 11(11):1071-1080. PubMed ID: 27626707
[TBL] [Abstract][Full Text] [Related]
16. Acquired expression of osteopontin selectively promotes enrichment of leukemia stem cells through AKT/mTOR/PTEN/β-catenin pathways in AML cells.
Mohammadi S; Ghaffari SH; Shaiegan M; Zarif MN; Nikbakht M; Akbari Birgani S; Alimoghadam K; Ghavamzadeh A
Life Sci; 2016 May; 152():190-8. PubMed ID: 27063991
[TBL] [Abstract][Full Text] [Related]
17. Targeting cancer stem cells with natural products.
Burnett J; Newman B; Sun D
Curr Drug Targets; 2012 Jul; 13(8):1054-64. PubMed ID: 22594473
[TBL] [Abstract][Full Text] [Related]
18. The molecular mechanisms of curcumin's inhibitory effects on cancer stem cells.
Zendehdel E; Abdollahi E; Momtazi-Borojeni AA; Korani M; Alavizadeh SH; Sahebkar A
J Cell Biochem; 2019 Apr; 120(4):4739-4747. PubMed ID: 30269360
[TBL] [Abstract][Full Text] [Related]
19. Curcumin suppresses stem-like traits of lung cancer cells via inhibiting the JAK2/STAT3 signaling pathway.
Wu L; Guo L; Liang Y; Liu X; Jiang L; Wang L
Oncol Rep; 2015 Dec; 34(6):3311-7. PubMed ID: 26397387
[TBL] [Abstract][Full Text] [Related]
20. Amide-linked local anesthetics preferentially target leukemia stem cell through inhibition of Wnt/β-catenin.
Ni J; Xie T; Xiao M; Xiang W; Wang L
Biochem Biophys Res Commun; 2018 Sep; 503(2):956-962. PubMed ID: 29932919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]